Influenzinum (2021-2022), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
Influenzinum (2021-2022), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Vir Combination. Available dosage form: liquid.
Drug details
- Generic Name
- Influenzinum (2021-2022), Herpes Simplex 1 Nosode, Herpes Simplex 2 Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Cytomegalovirus Nosode, Hepatitis B Nosode, Adenoviren Nosode, Epstein-Barr Virus Nosode
- Brand Names
- Vir Combination
- Sponsor
- Deseret Biologicals, Inc.
- NDC Codes
- 1
- Dosage Forms
- LIQUID
- Routes
- ORAL
- Active Ingredients
- INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED), HUMAN HERPESVIRUS 1, HUMAN HERPESVIRUS 2, HUMAN HERPESVIRUS 6, HUMAN HERPESVIRUS 5, HEPATITIS B VIRUS, HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN, HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN, HUMAN HERPESVIRUS 4
Indications and Usage
DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use. Tamper seal: "Sealed for Your Protection." Do not use if seal is broken or missing.